NELL-1 is a novel secreted protein associated with premature fusion of cranial sutures in craniosynostosis that has been found to promote osteoblast cell differentiation and mineralization. Our previous study showed that Runx2, the key transcription factor in osteoblast differentiation, transactivates the NELL-1 promoter. In this study, we evaluated the regulatory involvement and mechanisms of Osterix, an essential transcription factor of osteoblasts, in NELL-1 gene expression and function. Promoter analysis showed a cluster of potential Sp1 sites (Sp1/Osterix binding sites) within approximately 70 bp (from ？71 to ？142) of the 5′ flanking region of the human NELL-1 transcriptional start site. Luciferase activity in our NELL-1 promoter reporter systems was significantly decreased in Saos-2 cells when Osterix was overexpressed. Mutagenesis study demonstrated that this suppression is mediated by the Sp1 sites. The binding specificity of Osterix to these Sp1 sites was confirmed in Saos-2 cells and primary human osteoblasts by EMSA in vitro and ChIP assay in vivo. ChIP assay also showed that Osterix downregulated NELL-1 by affecting binding of RNA polymerase II to the NELL-1 promoter, but not by competing with Runx2 binding to the OSE2 sites. Moreover, NELL-1 mRNA levels were significantly decreased when Osterix was overexpressed in Saos-2, U2OS, Hela and Glioma cells. Correspondingly, knockdown of Osterix increased NELL-1 transcription and osteoblastic differentiation in both Saos-2 cells and primary human osteoblasts. These results suggest that Osterix is a direct transcriptional regulator with repressive effect on NELL-1 gene expression, contributing to a delicate balance of regulatory effects on NELL-1 transcription with Runx2, and may play a crucial role in osteoblast differentiation and mineralization. These findings also extend our understanding of the molecular mechanism of Runx2, Osterix, and NELL-1 and demonstrate their crosstalk during osteogenesis.
References
[1]
Matsuhashi S, Noji S, Koyama E, Myokai F, Ohuchi H, et al. (1995) New gene, nel, encoding a M(r) 93 K protein with EGF-like repeats is strongly expressed in neural tissues of early stage chick embryos. Dev Dyn 203: 212–222.
[2]
Watanabe TK, Katagiri T, Suzuki M, Shimizu F, Fujiwara T, et al. (1996) Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. Genomics 38: 273–276.
[3]
Truong T, Zhang X, Pathmanathan D, Soo C, Ting K (2007) Craniosynostosis-associated gene nell-1 is regulated by runx2. J Bone Miner Res 22: 7–18.
[4]
Ting K, Vastardis H, Mulliken JB, Soo C, Tieu A, et al. (1999) Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res 14: 80–89.
[5]
Zhang X, Kuroda S, Carpenter D, Nishimura I, Soo C, et al. (2002) Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest 110: 861–870.
[6]
Desai J, Shannon ME, Johnson MD, Ruff DW, Hughes LA, et al. (2006) Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum Mol Genet 15: 1329–1341.
[7]
Zhang X, Ko T, Pathmanathan D, Lee H, Chen F, et al. (2008) Craniofacial Bone Defect in Nell-1 Mutant Mice Associated with Disregulated Runx2 and Osx Expression. J Bone Miner Res 23: S99.
[8]
Zhang X, Ting K, Bessette CM, Culiat CT, Sung SJ, et al. (2010) Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice. J Bone Miner Res 26: 777–791.
[9]
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, et al. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17–29.
[10]
Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, et al. (2005) NFAT and Osterix cooperatively regulate bone formation. Nat Med 11: 880–885.
[11]
Karsenty G (2008) Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9: 183–196.
[12]
Nishio Y, Dong Y, Paris M, O'Keefe RJ, Schwarz EM, et al. (2006) Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372: 62–70.
[13]
Ulsamer A, Ortuno MJ, Ruiz S, Susperregui AR, Osses N, et al. (2008) BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem 283: 3816–3826.
[14]
Nakashima K, de Crombrugghe B (2003) Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19: 458–466.
[15]
Kaback LA, Soung do Y, Naik A, Smith N, Schwarz EM, et al. (2008) Osterix/Sp7 regulates mesenchymal stem cell mediated endochondral ossification. J Cell Physiol 214: 173–182.
[16]
Aghaloo T, Cowan CM, Chou YF, Zhang X, Lee H, et al. (2006) Nell-1-induced bone regeneration in calvarial defects. Am J Pathol 169: 903–915.
[17]
Goto T, Matsui Y, Fernandes RJ, Hanson DA, Kubo T, et al. (2006) Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells. J Bone Miner Res 21: 661–673.
[18]
McQuillan DJ, Richardson MD, Bateman JF (1995) Matrix deposition by a calcifying human osteogenic sarcoma cell line (SAOS-2). Bone 16: 415–426.
[19]
Rao LG, Liu LJ, Murray TM, McDermott E, Zhang X (2003) Estrogen added intermittently, but not continuously, stimulates differentiation and bone formation in SaOS-2 cells. Biol Pharm Bull 26: 936–945.
[20]
Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755–764.
[21]
Cowan CM, Cheng S, Ting K, Soo C, Walder B, et al. (2006) Nell-1 induced bone formation within the distracted intermaxillary suture. Bone 38: 48–58.
[22]
Zhang C, Cho K, Huang Y, Lyons JP, Zhou X, et al. (2008) Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci U S A 105: 6936–6941.
[23]
Cao Y, Jia SF, Chakravarty G, de Crombrugghe B, Kleinerman ES (2008) The osterix transcription factor down-regulates interleukin-1 alpha expression in mouse osteosarcoma cells. Mol Cancer Res 6: 119–126.
[24]
Cook T, Gebelein B, Urrutia R (1999) Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors. Ann N Y Acad Sci 880: 94–102.
[25]
Sinha KM, Yasuda H, Coombes MM, Dent SY, de Crombrugghe B (2010) Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J 29: 68–79.
[26]
Komori T (2006) Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 99: 1233–1239.
[27]
Deng ZL, Sharff KA, Tang N, Song WX, Luo J, et al. (2008) Regulation of osteogenic differentiation during skeletal development. Front Biosci 13: 2001–2021.
[28]
Lemon B, Tjian R (2000) Orchestrated response: a symphony of transcription factors for gene control. Genes Dev 14: 2551–2569.
